Year: 2026
Type: article
Abstract: Regular measurements of oxygen (O 2 ) and carbon dioxide (CO 2 ) are crucial for evaluation of the respiratory status in patients with moderate and advanced COPD. While O 2 monitoring is well established by pulse oximetry, there are still no established methods for non-invasive home measurements of CO 2 in patients during spontaneous breathing. Until now, patients must consult specialists or clinics for standardized procedures such as blood gas analysis (BGA) or transcutaneous capnometry (tCO 2 ). We therefore investigated a new hand-held device (Lumetry), based on volumetric and spirometric capnography with modernized algorithms for COPD patients during calm, spontaneous breathing (exclusion criterion RR > 21/min) and optimized beathing maneuvers. The aim of the study was to assess (1) the safety and usability of Lumetry and (2) agreement with well-established measurement methods BGA und tCO 2 . In this single-center prospective study, electively admitted patients with COPD GOLD 3 or 4 underwent spirometric capnography CO 2 measurements (petCO 2 ). Patients were stratified according to presence of hypercapnia as defined by a daytime paCO 2 >45 mmHg. End-tidal (petCO 2 ) values were translated to pCO 2 per device specific algorithms. Different breathing maneuvers (rested breathing, one deep exhalation, two deep in- and exhalations), were performed and the Lumetry results were compared with standardized CO 2 procedures in capillary blood gas analysis (Siemens, RAPIDpoint 500) and transcutaneous CO 2 measurement (Radiometer TCM5). Agreement between measurement methods were assessed using Bland-Altman analysis calculating mean bias and limits of agreement (LoA) 57 patients (32 women) were included in the analysis of whom 30 (52.6%) had hypercapnia. In the overall cohort, Lumetry slightly underestimated pCO 2 values compared to capillary blood gas analysis (CBG) during rested breathing (mean bias 6.1 mmHg, 95% LoA − 2.6 to 14.8 mmHg). Best agreement was observed for the deep breath mean maneuver (bias 2.1 mmHg, LoA − 8.2 to 12.4 mmHg). When stratified by hypercapnia status, the same pattern was observed. Lumetry showed similar agreement to CBG when compared to standard transcutaneous CO 2 levels (bias − 1.7 mmHg, LoA − 10.4 to 7.0 mmHg). There were no safety restrictions and the Lumetry device was easy to handle. Capnographic Lumetry measurements showed acceptable limits of agreement to capillary blood gas analysis. They furthermore proved non-inferior to transcutaneous CO 2 measurements. Results were consistent in hypercapnic and non-hypercapnic COPD patients and optimized by adapted deep breathing maneuvers. The Lumetry device was safe and easy to use. These promising results highlight its potential for home-based CO 2 monitoring and early detection of hypercapnic exacerbations.
Source: Scientific Reports
Language: English
Subfield: Pulmonary and Respiratory Medicine
Field: Medicine
Domain: Health Sciences
Open Access status: gold
Estimated APC paid: $2,690
Funder: Universitätsklinikum Heidelberg
OpenAlex ID: W7234565882
